-
MSI comment on decision to block FDA approval of mifepristone
Last Friday, a US federal judge moved to block the approval of mifepristone, one of two drugs used in more than half of all abortions in the United States. This decision is based on ideology, not evidence. Read our full statement.
-
5 key moments in the fight for reproductive rights in 2023 so far
We’re a quarter of the way into the year, and the global pro-choice community are already making waves with a definitive show of solidarity and action. Fronting up to anti-choice opposition, we’re making progress with grassroots advocacy, national policy change, and stigma-busting communications campaigns. People everywhere continue to fight for hard-won rights. We’ve rounded up…
-
MSI comment on UK’s new Women and Girls Strategy
MSI comment on the UK Foreign, Commonwealth and Development Office’s (FCDO) new Women and Girls strategy.
-
‘Crisis pregnancy centres’: the anti-choice movement in disguise
Anti-abortion centres, branded as ‘crisis pregnancy centres’, are in the spotlight after a recent BBC Panorama documentary in the UK investigated their agenda and conduct. The centres say they help women who are grappling with unplanned pregnancies by offering advice, counselling, and options, but the reality can be quite different—they’re often designed to prevent people…
-
Modern US abortion law & its impact on the world
Explore 50 years of US abortion laws and their impact on health and rights around the world, from Trump’s Global Gag Rule to the overturning of Roe Vs. Wade in 2022, and the global ramifications.
-
A year like no other: five big wins for reproductive rights in 2022
This was a turbulent year for abortion rights. But step by step, country by country, inspiring progress is being made. Here are five big moments of progress in global reproductive rights that we’re proud to have been part of this year.
-
Five things MSI learned at ICFP on delivering reproductive healthcare
MSI Reproductive Choices was proud to sponsor and attend the International Conference on Family Planning (ICFP) last month in Thailand. MSI colleagues from across our global partnership, from Papua New Guinea to Niger to Bangladesh, were there sharing …
-
MSI Reproductive Choices’ comment on UK vote in favour of national abortion clinic buffer zones
Today, the House of Commons has voted in favour of national legislation on abortion clinic buffer zones in England and Wales. Read MSI’s comment.
-
The Supreme Court of India declares abortion as a fundamental right
MSI welcomes the Supreme Court of India’s declaration that abortion is a fundamental right. Read our full comment.
-
Global DEI Strategy
Our Diversity, Equality & Inclusion Strategy is intended to provide a framework to support every MSI country as they embark on their own DEI journey.
